The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register
Open accessAbstract
OBJECTIVE: To assess the relative risk of major congenital malformation (MCM) from in utero exposure to antiepileptic drug (AEDs). METHODS: Prospective data collected by the UK Epilepsy and Pregnancy Register were analysed. The presence of MCMs recorded within the first three months of life was the main outcome measure. RESULTS: Full outcome data were collected on 3607 cases. The overall MCM rate for all AED exposed cases was 4.2% (95% confidence interval (CI), 3.6% to 5.0%). The MCM rate was higher for polytherapy (6.0%) (n = 770) than for monotherapy (3.7%) (n = 2598) (crude odds ratio (OR) = 1.63 (p = 0.010), adjusted OR = 1.83 (p = 0.002)). The MCM rate for women with epilepsy who had not taken AEDs during pregnancy (n = 239) was 3.5% (1.8% to 6.8%). The MCM rate was greater for pregnancies exposed only to valproate (6.2% (95% CI, 4.6% to 8.2%) than only to carbamazepine (2.2% (1.4% to 3.4%) (OR = 2.78 (p<0.001); adjusted OR = 2.97 (p<0.001)). There were fewer MCMs for pregnancies exposed only to lamotrigine than only to valproate. A positive dose response for MCMs was found for lamotrigine (p = 0.006). Polytherapy combinations containing valproate carried a higher risk of MCM than combinations not containing valproate (OR = 2.49 (1.31 to 4.70)). CONCLUSIONS: Only 4.2% of live births to women with epilepsy had an MCM. The MCM rate for polytherapy exposure was greater than for monotherapy exposure. Polytherapy regimens containing valproate had significantly more MCMs than those not containing valproate. For monotherapy exposures, carbamazepine was associated with the lowest risk of MCM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Probable Inference, the Law of Succession, and Statistical Inference
Wilson, E. B. (1927) · Journal of the American Statistical Association · doi:10.1080/01621459.1927.10502953 · Cited by 4,476
Hauser, W. A., Annegers, J. F., & Rocca, W. A. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.6.576 · Cited by 698
The Teratogenicity of Anticonvulsant Drugs
Holmes, L. B., Harvey, E. A., Coull, B. A., Huntington, K. B., Khoshbin, S., Hayes, A. M., & Ryan, L. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104123441504 · Cited by 655
Spina Bifida in Infants of Women Treated with Carbamazepine during Pregnancy
Rosa, F. W. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103073241006 · Cited by 452
Samrén, E. B., van Duijn, C. M., Koch, S., Hiilesmaa, V. K., Klepel, H., Bardy, A. H., Mannagetta, G. B., Deichl, A. W., Gaily, E., Granström, I. L., et al. (1997) · Epilepsia · doi:10.1111/j.1528-1157.1997.tb01480.x · Cited by 406
Increased rate of major malformations in offspring exposed to valproate during pregnancy
Wyszynski, D. F., Nambisan, M., Surve, T., Alsdorf, R. M., Smith, C. R., & Holmes, L. B. (2005) · Neurology · doi:10.1212/01.wnl.0000154516.43630.c5 · Cited by 390
Congenital malformations due to antiepileptic drugs
Kaneko, S., Battino, D., Andermann, E., Wada, K., Kan, R., Takeda, A., Nakane, Y., Ogawa, Y., Avanzini, G., Fumarola, C., et al. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(98)00084-9 · Cited by 374
Lamotrigine and the risk of malformations in pregnancy
Cunnington, M., Tennis, P., & the International Lamotrigine Pregnancy Registry Scientific Advisory Committee (2005) · Neurology · doi:10.1212/01.wnl.0000154515.94346.89 · Cited by 348
Lamotrigine and the risk of malformations in pregnancy
Hauser, W. A., & Tomson, T. (2006) · Neurology · doi:10.1212/01.wnl.0000203710.88804.29 · Cited by 314
Wide, K., Winbladh, B., & Källén, B. (2004) · Acta Paediatrica · doi:10.1111/j.1651-2227.2004.tb00701.x · Cited by 264
The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort.
Omtzigt, J. G. C., Los, F. J., Grobbee, D. E., Pijpers, L., Jahoda, M. G. J., Brandenburg, H., Stewart, P. A., Gaillard, H. L., Sachs, E. S., & Wladimiroff, J. W. (1992) · PubMed · Cited by 252
The AED (Antiepileptic Drug) Pregnancy Registry: A 6-Year Experience
Holmes, L. B. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.673 · Cited by 226
Dansky, L. V., & Finnell, R. H. (1991) · Reproductive Toxicology · doi:10.1016/0890-6238(91)90091-s · Cited by 209
Arpino, C., Brescianini, S., Robert, E., Castilla, E. E., Cocchi, G., Cornel, M. C., de Vigan, C., Lancaster, P. A. L., Merlob, P., Sumiyoshi, Y., et al. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00119.x · Cited by 207
Pregnancies of Women with Epilepsy: A Population‐Based Study in Iceland
Olafsson, E., Hallgrimsson, J. T., Hauser, W. A., Ludvigsson, P., & Gudmundsson, G. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01186.x · Cited by 192
Vajda, F. J., O'Brien, T. J., Hitchcock, A., Graham, J., Cook, M., Lander, C., & Eadie, M. J. (2004) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2004.05.003 · Cited by 177
Spectrum of neural-tube defects in 34 infants prenatally exposed to antiepileptic drugs.
Lindhout, D., Omtzigt, J. G. C., & Cornel, M. C. (1992) · PubMed · Cited by 154
Sleep in Alzheimer's disease and the sundown syndrome.
Vitiello, M. V., Bliwise, D. L., & Prinz, P. N. (1992) · PubMed · Cited by 144
Epilepsy, pregnancy, and the child
Janz, D. (1982) · Raven Press eBooks · Cited by 143
Epilepsy and pregnancy: lamotrigine as main drug used
Sabers, A., Dam, M., Rogvi-Hansen, B. Á., Boas, J., Sidenius, P., Friis, M. L., Alving, J., Dahl, M., Ankerhus, J., & Dam, A. M. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.00200.x · Cited by 133
Prevention of stroke with ticlopidine
Grotta, J. C., Norris, J. W., Kamm, B., & Subgroup, T. B. A. A. D. (1992) · Neurology · doi:10.1212/wnl.42.1.111 · Cited by 132
The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months
Vajda, F. J. E., O'Brien, T. J., Hitchcock, A. A., Graham, J. E., & Lander, C. M. (2003) · Journal of Clinical Neuroscience · doi:10.1016/s0967-5868(03)00158-9 · Cited by 128
Preliminary Results on Pregnancy Outcomes in Women Using Lamotrigine
Tennis, P. S., & Eldridge, R. R. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.45901.x · Cited by 115
Major and minor birth malformations and antiepileptic drugs.
Koch, S., Lösche, G., Jäger‐Roman, E., Jakob, S., Rating, D., Deichl, A., & Helge, H. (1992) · PubMed · Cited by 114
Oxcarbazepine in pregnancy: clinical experience in Argentina
Meischenguiser, R., D’Giano, C., & Ferraro, S. M. (2004) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2003.11.020 · Cited by 89
EURAP: An International Registry of Antiepileptic Drugs and Pregnancy
Tomson, T., Battino, D., Bonizzoni, E., Craig, J. J., Lindhout, D., Perucca, E., Sabers, A., Vajda, F. J. E., & Collaborative EURAP Study Group (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.451101.x · Cited by 80
North American Antiepileptic Drug Pregnancy Registry
Holmes, L. B., & Wyszynski, D. F. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.451102.x · Cited by 77
Wide, K., Winbladh, B., & n, B. K. X. E. L. X. E. (2004) · Acta Paediatrica · doi:10.1080/08035250310021118 · Cited by 64
Australian Pregnancy Registry of Women Taking Antiepileptic Drugs
Vajda, F. J. E., Lander, C. M., O'Brien, T. J., Hitchcock, A. A., Graham, J. E., Solinas, C., Eadie, M. J., & Cook, M. J. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.451103.x · Cited by 48
U.K. Epilepsy and Pregnancy Group
Russell, A., Craig, J. J., Morrison, P. J., Irwin, B., Waddell, R., Parsons, L., Robertson, I., Guthrie, E., & Morrow, J. I. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.451104.x · Cited by 27
Self-citationAnti-epileptic drugs in pregnancy: current safety and other issues
Morrow, J., & Craig, J. J. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.4.445 · Cited by 27
Self-citationSperfeld (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199911)46:5 · Cited by 2
Cited by
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
Marson, A. G., Al-Kharusi, A. M., Alwaidh, M., Appleton, R., Baker, G. A., Chadwick, D. W., Cramp, C., Cockerell, O. C., Cooper, P. N., Doughty, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60461-9 · Cited by 969
Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs
Meador, K. J., Baker, G. A., Browning, N., Clayton-Smith, J., Combs-Cantrell, D. T., Cohen, M., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803531 · Cited by 812
Tomson, T., Battino, D., Bonizzoni, E., Craig, J., Lindhout, D., Sabers, A., Perucca, E., & Vajda, F. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70107-7 · Cited by 751
Adverse effects of antiepileptic drugs
Perucca, P., & Gilliam, F. G. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70153-9 · Cited by 694
Metadata
- Authors
- Morrow, J.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2006-02-01
- Volume
- 77
- Issue
- 2
- Pages
- 193-198
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2119186079
- Cited by
- 880
- References
- 32
- FWCI
- 52.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.